Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS
Lin Elizabeth Yeu sold 11,578 Tarsus Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026
From Sep 1 to Sep 2, 2026, Lin Elizabeth Yeu (Chief Medical Officer) sold 11,578 Tarsus Pharmaceuticals, Inc. shares at an average US$77.56 for US$898K under a trading plan, leaving 4,770 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 11,578 shares
- Price
- US$77.56 average (US$73.86 to US$80.00)
- Value
- US$898K
- Holding after
- 4,770 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Sale | 4,601 | US$73.86 | 18,707 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 5,387 | US$80.00 | 13,320 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 1,590 | US$80.00 | 4,770 | Indirect |
Source
Related
- Tarsus Pharmaceuticals, Inc.
- Lin Elizabeth Yeu
- Tarsus Pharmaceuticals, Inc. shareholders
- Form 4 · Lin Elizabeth Yeu · Sep 9, 2026
- Form 4 · Pyott David E I · Sep 17, 2026
- Form 4 · Yarno Wendy L · Sep 17, 2026
- Form 4 · Link William J Phd · Sep 17, 2026
- Form 4 · Azamian Bobak R. · Sep 9, 2026
- Form 4 · Neervannan Seshadri · Sep 9, 2026